| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 10/05/1999 | US5962256 Nuclear thyroid hormone receptor-interacting polynucleotides and related molecules and methods |
| 09/30/1999 | WO1999048925A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/30/1999 | WO1999048477A1 Topical hormonal composition with systemic effect |
| 09/30/1999 | WO1999041411A3 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor |
| 09/30/1999 | WO1999027897A9 Site-specific preparation of polyethylene glycol-grf conjugates |
| 09/30/1999 | CA2324340A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 09/29/1999 | EP0944648A1 Glp-1 derivatives |
| 09/29/1999 | EP0944613A1 Novel benzopyran derivatives |
| 09/29/1999 | CN1230121A Means for treating prostate hypertrophy and prostate cancer |
| 09/29/1999 | CN1230114A Novel treatment of leptine resistance |
| 09/28/1999 | US5959109 Compounds and methods for increasing endogenous levels of corticotropin-releasing factor |
| 09/28/1999 | US5958979 Stabilized medicaments containing thyroid hormones |
| 09/28/1999 | US5958969 Osteoporosis |
| 09/28/1999 | US5958936 For inducing antiandrogenic activity in warm-blooded animals, including humans |
| 09/28/1999 | US5958916 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 09/28/1999 | US5958731 Cell junction PDZ protein |
| 09/23/1999 | WO1999047545A2 Inhibitors of caspases |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 09/23/1999 | WO1999012531A3 Hormonal contraceptive |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942919A2 Compound |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942755A2 Treatment of diabetes with transcription factor gene |
| 09/22/1999 | EP0804223B1 Hgh containing pharmaceutical compositions |
| 09/21/1999 | US5955574 Analogs of parathyroid hormone |
| 09/21/1999 | US5955455 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/21/1999 | US5955440 Macrolide LHRH antagonists |
| 09/21/1999 | US5955346 Variants of human prolactin and human placeatal lactogen |
| 09/21/1999 | US5955105 Stabilized thyroid hormone preparations and methods of making same |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046268A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | CA2323493A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 09/16/1999 | CA2323089A1 Inhibitors of type 5 and type 3 17.beta.-hydroxysteroid dehydrogenase and methods for their use |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941067A2 Stable glassy state powder formulations |
| 09/15/1999 | CN1228758A Haphthyl compounds, intermediates, compositions and methods of use |
| 09/15/1999 | CN1228303A Drug composition for curing gynaecological vaginitis |
| 09/14/1999 | US5952356 Treating diabetes in a mammal with an active material and a glucosidase inhibitor |
| 09/14/1999 | US5952319 Controlling male fertility in mammal |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045029A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
| 09/10/1999 | WO1999045024A1 Cholenic acid amides and pharmaceutical compositions thereof |
| 09/10/1999 | WO1999045022A1 20-KETO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES |
| 09/10/1999 | WO1999044613A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v1a and v2 receptors |
| 09/10/1999 | WO1999031262A3 Needle-free injection of formulated nucleic acid molecules |
| 09/10/1999 | WO1999021617B1 Allosteric adenosine receptor modulators |
| 09/10/1999 | CA2322051A1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphthyl)ethyl)amide |
| 09/08/1999 | EP0939751A1 Macrophage lipid chemoattractant |
| 09/08/1999 | EP0871463A4 Regulation of eating behavior |
| 09/08/1999 | CN1228091A Substituted 6,6-hetero-bicyclic derivatives |
| 09/08/1999 | CN1227871A Nuclein structural body for gene treating method |
| 09/07/1999 | US5948809 (-) cis-6(S)-phenyl-5(R) 4-(2-pyrrolidin-1-yl ethoxy) phenyl!-5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate |
| 09/07/1999 | US5948796 Benzo B!thiophene compounds, intermediates, formulations, and methods |
| 09/07/1999 | US5948795 Benzothiopene compounds, and uses and formulations thereof |
| 09/07/1999 | US5948434 Administering dehydroepiandrosterone or dehydroepiandrosterone sulphate via transdermal patch |
| 09/02/1999 | WO1999043707A1 N-terminally modified glp-1 derivatives |
| 09/02/1999 | WO1999043706A1 Derivatives of glp-1 analogs |
| 09/02/1999 | WO1999043705A1 N-terminally truncated glp-1 derivatives |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | WO1998027113A8 Melanocortin derivatives for specific binding of melanocortin receptor 3, 4 or 5 |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |
| 09/01/1999 | EP0886645B1 New 19-nor-pregnene derivatives |
| 09/01/1999 | EP0752882A4 Treatment for juvenile diabetes |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 09/01/1999 | CN1227503A Novel device for transdermal administering of trimegestone |
| 08/31/1999 | CA2118030C Drug for increasing the level of testosterone in the body |
| 08/26/1999 | WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | WO1999042127A2 Receptor derived peptides as modulators of receptor activity |
| 08/26/1999 | WO1999042109A1 Combination preparation of estrogen and anti-estrogen |
| 08/26/1999 | WO1999028342A3 Low-voltage activated calcium channel compositions and methods |
| 08/26/1999 | DE19807791A1 Combination preparation of estrogen with 7-aminoalkyl-estratriene antiestrogen, useful in hormone replacement therapy, e.g. for treatment osteoporosis, Alzheimer's disease and hot flushes |
| 08/26/1999 | CA2322200A1 Receptor derived peptides as modulators of receptor activity |
| 08/26/1999 | CA2321427A1 Combination preparation of estrogen and anti-estrogen |
| 08/26/1999 | CA2321182A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/25/1999 | EP0937062A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937061A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937060A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937059A1 NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937058A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/25/1999 | EP0937057A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | CN1226929A Valtage-gated calcium channel antagonist and methods |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/19/1999 | WO1999041411A2 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 08/19/1999 | WO1999041252A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | WO1999041251A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | WO1999030708A3 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1998030590A9 Analogs of parathyroid hormone |
| 08/19/1999 | DE19806438A1 New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer |
| 08/19/1999 | CA2319065A1 Method for diagnosis and treatment of disorders of carbohydrate metabolism |
| 08/19/1999 | CA2318957A1 Antagonists of gonadotropin releasing hormone |